| 6.500 0 (0%) 04-24 21:47 |
|
| Open: | 6.100 |
| High: | 6.620 |
| Low: | 6.070 |
| Pre. close: | 6.500 |
| Volume: | 63,830 |
| Avg. volume: | 45,756 |
| MA (50): | 6.435 |
| MA (200): | 7.500 |
| Year high: | 14.300 |
| Year low: | 3.730 |
| Market cap: | 0(M) |
| EPS: | -1.771 |
| PE ratio: | -3.67 |
| SELL | BUY |
| HeikinAshi: | |
| Kaufmans AMA: | |
| Chandelier (20): | |
| MA (5): | |
| MA (50): | |
| MACD (26,12,9): | |
| Slow KDJ (14,3): | |
| RSI (14): | |
| CCI (20): |
Tue, 02 Jun 2026
Advicenne's Stock Soars Over 55% in a Week Following Approval of Likozam - Idéal Investisseur
Mon, 01 Jun 2026
Advicenne soars as Likozam secures social security reimbursement - marketscreener.com
Mon, 01 Jun 2026
Advicenne: Likozam to be Reimbursed Starting June 2026, Claims €6M from the State - Idéal Investisseur
Tue, 24 Feb 2026
N4 Pharma plc (AIM: N4P) CEO Appointment & Name Change Thalia Therapeutics - Share Talk
Mon, 24 Jun 2024
Navigating the global epilepsy clinical trial landscape in 2024 - Clinical Trials Arena
Mon, 15 Jun 2026
©NovaStocks.com | euro Stocks quote, company news, stock charts, technical analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither NovaStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: Financial Modeling Prep
Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Third parties' use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.